For more than a month, the U.S. Hospitals have more than 100,000 coronavirus patients every day

A nurse receives a dose of the Pfizer-Bioentech Covid-19 vaccine on December 22, 2020 in Hexby, England.
Nurses receive a dose of the Pfizer-Bioentech Covid-19 vaccine on December 22, 2020 in Hexby, England Lindsay Parnabi / AFP / Getty Images

Britain aims to complete “tens of millions” of Covid-19 vaccinations in the next three months, UK Prime Minister Boris John said on Sunday.

Speaking to the BBC, Johnson said: “We hope we can make a million [of Covid-19 vaccines] In the next three months, I can definitely give you that figure, ‘he added.

Johnson said the strategy is based on three vaccines, the Pfizer / Bioentech vaccine and the Oxford / AstraZeneca vaccine – both approved in the UK – and the Moderna vaccine, which will be ready for use soon.

Echoing what the Prime Minister said in October last year, he said: “I thought that by spring things would be better. I’m sticking. “

Asked about the number of doses from the Xford / AstraZeneca Covid-19 vaccine, which was approved by UK regulators on Wednesday, Johnson said 530,000 doses would be ready to be inoculated on Monday, with the Phiser / Bioentechcovid-19 vaccine delivered on top.

On Sunday, UK Health Secretary Matt Hancock said on Twitter that 1 million Pfizer / Bioentech Covid-19 vaccines had been given in the country, saying “the end is near.”

UK Vaccine Guide improves: Last week, the UK’s chief medical officer issued revised advice on the recommended interval between vaccine doses for coronavirus vaccine developed by Pfizer and Bioentech.

UK regulators had previously recommended that a second dose of the Pfizer / Bioentech vaccine be given three weeks after the first dose, with UK medical officials this week advising that it be given between 3 and 12 weeks after the first dose. Similarly, a second dose of the new UK-authorized Oxford / AstraZeneca vaccine, according to the recommendations, is given 4 to 12 weeks after the first.

In a letter to healthcare professionals, the chief medical officer on Thursday defended his decision to extend the interval for patients awaiting a second dose of the Pfizer / Bioentech vaccine, saying the decision was based on a balanced assessment of their risks and benefits. .

The British Medical Association said the move was “absolutely unfair” to thousands of at-risk patients across the country.

Pfizer says it has no data to show that a single dose of its Covid-19 vaccine will provide protection against the disease after more than 21 days.